PW
BIIB icon

Price Wealth’s Biogen BIIB Stock Holding History

Price Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4
Closed -$1K – 421
2020
Q1 		$1K Hold
4
– – ﹤0.01% 279
2019
Q4 		$1K Buy
+4
New +$1.11K ﹤0.01% 276
2018
Q3 		– Sell
-57
Closed -$17K – 189
2018
Q2 		$17K Buy
57
+37
+185% +$10.4K 0.01% 217
2018
Q1 		$5K Sell
20
-20
-50% -$6.21K ﹤0.01% 226
2017
Q4 		$12K Buy
+40
New +$12.8K 0.01% 168

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Price Wealth's BIIB Position: Q2 2020 in Review

Price Wealth sold out of Biogen (BIIB) in Q2 2020, closing a stake of 4 shares — an estimated $1K sold.

Price Wealth first reported a position in BIIB in Q4 2017 and held it in 5 quarters. The position peaked at $17K in Q2 2018. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Price Wealth reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Price Wealth sold 4 Biogen shares in Q2 2020, an estimated $1K.
  • Price Wealth first reported a position in Biogen in Q4 2017 and held it in 5 quarters.
  • Price Wealth's Biogen position peaked at $17K in Q2 2018.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Price Wealth's 13F filing for Q2 2020, filed 21 Jul 2020.